Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph F Ebenbichler

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|September 25, 2009
Experimental antipsychotics and metabolic adverse effects--findings from clinical trialsAlexander Tschoner, W Wolfgang Fleischhacker, Christoph F Ebenbichler
Wiener Medizinische Wochenschrift (1946)|September 3, 2010
[Adipokine update - new molecules, new functions]Carmen Gelsinger, Alexander Tschoner, Susanne Kaser, et al.
Wiener Medizinische Wochenschrift (1946)|July 28, 2011
[Psychotropic drugs and diabetes]Claudia Ress, Alexander Tschoner, Susanne Kaser, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 18, 2007
Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysisJulia Engl, Maria Rettenbacher, Wolfgang W Fleischhacker, et al.
Obesity Research|June 14, 2003
Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndromeAnton Sandhofer, Markus Laimer, Christoph F Ebenbichler, et al.
Molecular Medicine (Cambridge, Mass.)|March 12, 2011
Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight lossAlexander R Moschen, Clemens Molnar, Barbara Enrich, et al.
International Clinical Psychopharmacology|December 5, 2013
Sibutramine in the treatment of antipsychotic-induced weight gain: a pilot study in patients with schizophreniaFalko Biedermann, W Wolfgang Fleischhacker, Georg Kemmler, et al.
European Heart Journal|July 16, 2009
Arrhythmias and increased neuro-endocrine stress response during physicians' night shifts: a randomized cross-over trialMarkus Rauchenzauner, Florian Ernst, Florian Hintringer, et al.
Obesity (Silver Spring, Md.)|February 2, 2008
The Taq1B-variant in the cholesteryl ester-transfer protein gene and the risk of metabolic syndromeAnton Sandhofer, Tobias Tatarczyk, Markus Laimer, et al.
Obesity (Silver Spring, Md.)|July 21, 2006
Cholesteryl ester transfer protein in metabolic syndromeAnton Sandhofer, Susanne Kaser, Andreas Ritsch, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Current Opinion in Investigational Drugs (London, England : 2000)|September 25, 2009
Experimental antipsychotics and metabolic adverse effects--findings from clinical trialsAlexander Tschoner, W Wolfgang Fleischhacker, Christoph F Ebenbichler
Wiener Medizinische Wochenschrift (1946)|September 3, 2010
[Adipokine update - new molecules, new functions]Carmen Gelsinger, Alexander Tschoner, Susanne Kaser, et al.
Wiener Medizinische Wochenschrift (1946)|July 28, 2011
[Psychotropic drugs and diabetes]Claudia Ress, Alexander Tschoner, Susanne Kaser, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 18, 2007
Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysisJulia Engl, Maria Rettenbacher, Wolfgang W Fleischhacker, et al.
Obesity Research|June 14, 2003
Soluble leptin receptor and soluble receptor-bound fraction of leptin in the metabolic syndromeAnton Sandhofer, Markus Laimer, Christoph F Ebenbichler, et al.
Molecular Medicine (Cambridge, Mass.)|March 12, 2011
Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight lossAlexander R Moschen, Clemens Molnar, Barbara Enrich, et al.
International Clinical Psychopharmacology|December 5, 2013
Sibutramine in the treatment of antipsychotic-induced weight gain: a pilot study in patients with schizophreniaFalko Biedermann, W Wolfgang Fleischhacker, Georg Kemmler, et al.
European Heart Journal|July 16, 2009
Arrhythmias and increased neuro-endocrine stress response during physicians' night shifts: a randomized cross-over trialMarkus Rauchenzauner, Florian Ernst, Florian Hintringer, et al.
Obesity (Silver Spring, Md.)|February 2, 2008
The Taq1B-variant in the cholesteryl ester-transfer protein gene and the risk of metabolic syndromeAnton Sandhofer, Tobias Tatarczyk, Markus Laimer, et al.
Obesity (Silver Spring, Md.)|July 21, 2006
Cholesteryl ester transfer protein in metabolic syndromeAnton Sandhofer, Susanne Kaser, Andreas Ritsch, et al.
Pageof 4